616.15↑1.55 (0.25%)
12:00 AM,29th Sep 2023616.90↑1.90 (0.31%)
12:00 AM,29th Sep 2023BSE : 590006
NSE : AMRUTANJAN
Sector : Health care
ISIN Code : INE098F01031
Last Updated: Sep 29 2023 | 12:00 AM IST
Market Cap (₹ Cr) | 1799 |
Turnover (₹ Cr) | 0.23 |
Volume (Shares) | 37601 |
Face Value | 1 |
52-WK High | 775.45 |
52-WK High Date | 30 Jun 2023 |
52-WK Low | 554.05 |
52-WK Low Date | 31 Mar 2023 |
All Time High | 1024.55 |
All Time High Date | 08 Nov 2021 |
All Time Low | 41.30 |
All Time Low Date | 05 Nov 2009 |
The Madras-based Amrutanjan manufactures bulk drugs and drug intermediateslike theophylline based on in-house research. Three plants have been set up in the Alandur industrial belt near Madras to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops.Amrutanjan also has an agreement with a company in Philadelphia US to supply custom-made chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill Amrutanjan gripe water sans alcohol Amrutanjan Maha Strong etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 1996-97 it has introduced a new product called 'Cold Snap Gel' and also a mint called 'tingle'. Company having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Ltd having holding stake 99.80% & Amrutanjan Finance Ltd having holding stake is 57.26%.Company has taken efforts to increase the export of fine chemicals & also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover & net Profit of the Company.'Diakyur' for the treatment of Diabetes was introduced during 2000-2001 and it has been well accepted by the customers. The company's R & D has been engaged in the development of neutraceuticals.The company is mainly focussing on Bio-Tech products and expects a good results from this division. During 2001-02 the company allotted 1600000 equity bonus shares of Rs.10/- each and subsequently the share capital has increased from Rs.1.60 crores to Rs.3.20 crores.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 1799 |
EPS - TTM (₹) [S] | 14.77 |
P/E Ratio (X) [S] | 6.19 |
Face Value (₹) | 1 |
Latest Dividend (%) | 260.00 |
Latest Dividend Date | 14 Sep 2023 |
Dividend Yield (%) | 0.74 |
Book Value Share (₹) [S] | 99.48 |
P/B Ratio (₹) [S] | 6.19 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|---|---|---|
DSP Small Cap Fund (G) | 90.11 | 1466269 | 0.75 |
DSP Small Cap Fund (IDCW) | 90.11 | 1466269 | 0.75 |
DSP Small Cap Fund - Direct (IDCW) | 90.11 | 1466269 | 0.75 |
DSP Small Cap Fund - Direct (G) | 90.11 | 1466269 | 0.75 |
Sundaram Small Cap Fund (IDCW) | 29.78 | 484538 | 1.15 |
Sundaram Small Cap Fund (G) | 29.78 | 484538 | 1.15 |
Sundaram Small Cap Fund - Direct (G) | 29.78 | 484538 | 1.15 |
Sundaram Small Cap Fund - Direct (IDCW) | 29.78 | 484538 | 1.15 |
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 613.15 624.85 |
Week Low/High | 611.00 650.00 |
Month Low/High | 606.55 660.00 |
Year Low/High | 554.05 775.00 |
All time Low/High | 5.05 1025.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -3.07% | -3.11% | -0.27 | -0.18% |
1 Month | 1.10% | 1.21% | 1.16 | 1.53% |
3 Month | -7.78% | -7.75% | 2.99 | 3.51% |
6 Month | 3.69% | 3.51% | 14.26 | 15.85% |
1 Year | -13.85% | -13.90% | 16.70 | 16.77% |
3 Year | 42.36% | 42.59% | 73.35 | 74.99% |
Date | Client Name | Exchange | Transaction | Quantity | Price |
---|---|---|---|---|---|
30-06-2023 | GRAVITON RESEARCH CAPITAL LLP | NSE | BUY | 191539 | 737.21 |
30-06-2023 | GRAVITON RESEARCH CAPITAL LLP | NSE | SELL | 191539 | 737.86 |
10-06-2020 | GRAVITON RESEARCH CAPITAL LLP | NSE | SELL | 152024 | 391.52 |
10-06-2020 | GRAVITON RESEARCH CAPITAL LLP | NSE | BUY | 152024 | 391.16 |
10-06-2020 | N.K.SECURITIES | NSE | BUY | 371237 | 384.97 |
10-06-2020 | N.K.SECURITIES | NSE | SELL | 371237 | 385.33 |
28-07-2015 | RAJASHEKAR SWAMINATHAN IYER | BSE | BUY | 122500 | 453.91 |
28-07-2015 | SECURITIES CAPITAL INV.LTD | BSE | SELL | 122500 | 453.85 |
26-11-2014 | RAJASHEKAR SWAMINATHAN IYER | BSE | SELL | 80000 | 461.52 |
26-11-2014 | SECURITIES CAPITAL INV.LTD | BSE | BUY | 80000 | 461.52 |
Load More |
Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
---|
Category | Share(%) |
---|---|
Promoter | 50.04 |
Financial Institutions Banks | 0.09 |
Foreign Institutional Investors | 0.70 |
Insurance Companies | 0.00 |
Mutual Funds Uti | 6.93 |
Other Institutional Investors | 0.20 |
Indian Public | 35.03 |
Others Non Institutional Investors | 6.84 |
Custodians | 0.18 |
Announcement Date | Purpose | From | To | Remarks |
---|---|---|---|---|
Data Not Found |
Search for Price History
Date | Open | High | Low | Close | Shares | Trades |
---|---|---|---|---|---|---|
Data Not Found |
Load more
CMD & Executive Director : S Sambhuprasad
Independent Non Exe. Director : Marie Shiranee Pereira
Independent Non Exe. Director : V Raja
Independent Non Exe. Director : Muralidharan Swayambunathan
Independent Non Exe. Director : Meena Lochani Raghunathan
Non Executive Director : Ramaa Prabhakar Arikirevula
Company Sec. & Compli. Officer : M Srinivasan.
Registered Office: New 103 Old 42-45 LuzChurch Rd, Mylapore,Chennai,Tamil Nadu-600004 Ph: 91-44-24994164/24994465/24994366
Email:shares@amrutanjan.com